CoChat

Can Physiologic Assessment and Side Effects Tease Out Differences in PTSD Trials? A Double-Blind Comparison of Citalopram, Sertraline, and Placebo

Tucker, Phebe, MD, Potter-Kimball, Robin, RN, MS, Wyatt, Dorothy B., RN, Parker, Don E., PhD, Burgin, Christie, PhD, Jones, Dan E., PhD, Masters, and Barbara K., MD · 2025 · Psychopharmacology Bulletin
Cited by 49

The DOI matches its Crossref record.

Abstract

Effects of double-blind treatment of chronic posttraumatic stress disorder (PTSD) with two SSRIs and placebo on emotional symptoms and autonomic reactivity were assessed prospectively. PTSD subjects received citalopram (n=25), sertraline (n=23), or placebo (n=10) for 10 weeks, with psychophysiologic assessments performed before and after treatment. Intent-to-treat analysis showed that all treatment groups improved significantly in total PTSD symptoms (as measured by the Clinician-Administered PTSD Scale), all three PTSD symptom clusters, and sleep time. However, subtle differences in improvements in PTSD symptom clusters, physiologic reactivity, and reported adverse events were identified. Citalopram-treated subjects significantly lowered systolic and diastolic blood pressures, while sertraline- and placebo-treated patients significantly lowered only systolic blood pressure reactivity to individualized trauma scripts. The sertraline group showed significantly more improvement in avoidance/numbing symptoms than both other groups. Considering side effects, subjects on sertraline reported more gastrointestinal problems, with early terminators having more insomnia. Early terminators on citalopram reported more fatigue and appetite changes than other treatment groups, with completers reporting more sexual dysfunction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.64719/pb.4179

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 49

Metadata

Authors
Tucker, P., MD, Potter-Kimball, R., RN, MS, Wyatt, D. B., RN, Parker, D. E., PhD, Burgin, C., PhD, Jones, D. E., PhD, Masters, A. B. K., & MD
Venue
Psychopharmacology Bulletin
Published
2025-08-12
Volume
37
Issue
3
Pages
135-149
ISSN
  • 0048-5764 (ISSN-L)
  • 2472-2448
OpenAlex
W2315542047
Cited by
49
References
0
FWCI
1.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Can Physiologic Assessment and Side Effects Tease Out Differences in PTSD Trials? A Double-Blind Comparison of Citalopram, Sertraline, and Placebo. https://app.cochat.ai/papers/10.64719/pb.4179
The paper
Tucker, P., MD, Potter-Kimball, R., RN, MS, Wyatt, D. B., RN, Parker, D. E., PhD, Burgin, C., PhD, Jones, D. E., PhD, Masters, A. B. K., & MD. (2025). Can Physiologic Assessment and Side Effects Tease Out Differences in PTSD Trials? A Double-Blind Comparison of Citalopram, Sertraline, and Placebo. Psychopharmacology Bulletin. https://doi.org/10.64719/pb.4179

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.